Select Updates for Guidance for the Non-Clinical and Clinical Investigation of Devices Used for the Treatment of Benign Prostatic Hyperplasia; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

Riepilogo

The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Select Updates for Guidance for the Non-Clinical and Clinical Investigation of Devices Used for the Treatment of Benign Prostatic Hyperplasia (BPH)." FDA has developed this draft guidance to propose select updates to certain sections of the existing FDA guidance document "Guidance for the Non[hyphen]Clinical and Clinical Investigation of Devices Used for the Treatment of Benign Prostatic Hyperplasia (BPH)." This draft guidance is not final nor is it in effect at this time.